WISP3
Reaktivität: Human
Wirt: Kaninchen
Polyclonal
FITC
Applikationshinweise
ELISA (1:1000) Western Blot (1:50-200) Immunohistochemistry (1:50-100) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Clark, Gurney, Abaya, Baker, Baldwin, Brush, Chen, Chow, Chui, Crowley, Currell, Deuel, Dowd, Eaton, Foster, Grimaldi, Gu, Hass, Heldens, Huang, Kim, Klimowski, Jin, Johnson, Lee, Lewis, Liao, Mark et al.: "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. ..." in: Genome research, Vol. 13, Issue 10, pp. 2265-70, (2003) (PubMed).
Kleer, Zhang, Pan, van Golen, Wu, Livant, Merajver: "WISP3 is a novel tumor suppressor gene of inflammatory breast cancer." in: Oncogene, Vol. 21, Issue 20, pp. 3172-80, (2002) (PubMed).
Tanaka, Sugimachi, Shimada, Maehara, Sugimachi: "Variant WISPs as targets for gastrointestinal carcinomas." in: Gastroenterology, Vol. 123, Issue 1, pp. 392-3, (2002) (PubMed).
Target
WISP3
(Wnt1 Inducible Signaling Pathway Protein 3 (WISP3))